Catherine Corrigan Sells 4,194 Shares of Exponent (NASDAQ:EXPO) Stock

Exponent, Inc. (NASDAQ:EXPO) CEO Catherine Corrigan sold 4,194 shares of Exponent stock in a transaction that occurred on Friday, May 15th. The stock was sold at an average price of $54.06, for a total value of $226,727.64. Following the transaction, the chief executive officer directly owned 105,218 shares in the company, valued at approximately $5,688,085.08. This trade represents a 3.83% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Catherine Corrigan also recently made the following trade(s):

• On Monday, March 16th, Catherine Corrigan sold 3,912 shares of Exponent stock. The stock was sold at an average price of $67.49, for a total value of $264,020.88.
• On Wednesday, April 15th, Catherine Corrigan sold 3,909 shares of Exponent stock. The stock was sold at an average price of $67.70, for a total value of $264,639.30.
• On Tuesday, February 17th, Catherine Corrigan sold 3,920 shares of Exponent stock. The shares were sold at an average price of $67.15, for a total value of $263,228.00.

Exponent Price Performance

Shares of NASDAQ:EXPO traded up $0.12 during trading on Friday, reaching $53.79. The company had a trading volume of 664,262 shares, compared to its average volume of 499,505. The firm has a market capitalization of $2.61 billion, a price-to-earnings ratio of 25.02 and a beta of 0.78. The stock’s fifty day moving average price is $65.71 and its 200 day moving average price is $69.74. Exponent, Inc. has a fifty-two week low of $51.91 and a fifty-two week high of $81.95.

Exponent (NASDAQ:EXPO) last released its earnings results on Thursday, April 30th. The business services provider reported $0.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.56 by $0.03. The business had revenue of $166.30 million for the quarter, compared to analyst estimates of $149.53 million. Exponent had a return on equity of 27.94% and a net margin of 18.07%.The company’s revenue for the quarter was up 14.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.52 earnings per share. On average, equities analysts anticipate that Exponent, Inc. will post 2.28 EPS for the current fiscal year.

Exponent Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, June 18th. Stockholders of record on Friday, June 5th will be issued a $0.31 dividend. The ex-dividend date of this dividend is Friday, June 5th. This represents a $1.24 dividend on an annualized basis and a dividend yield of 2.3%. Exponent’s payout ratio is presently 57.67%.

Institutional Trading of Exponent

A number of institutional investors have recently bought and sold shares of EXPO. United Services Automobile Association purchased a new stake in Exponent during the first quarter worth $270,000. Jane Street Group LLC lifted its position in shares of Exponent by 1,481.0% in the first quarter. Jane Street Group LLC now owns 127,222 shares of the business services provider’s stock valued at $10,313,000 after acquiring an additional 119,175 shares in the last quarter. Invesco Ltd. lifted its position in shares of Exponent by 3.3% in the second quarter. Invesco Ltd. now owns 554,733 shares of the business services provider’s stock valued at $41,444,000 after acquiring an additional 17,930 shares in the last quarter. First Trust Advisors LP purchased a new stake in shares of Exponent in the second quarter valued at $18,377,000. Finally, Walleye Capital LLC lifted its position in shares of Exponent by 7.5% in the second quarter. Walleye Capital LLC now owns 6,623 shares of the business services provider’s stock valued at $495,000 after acquiring an additional 464 shares in the last quarter. 92.37% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on the company. JPMorgan Chase & Co. dropped their target price on Exponent from $95.00 to $80.00 and set an “overweight” rating on the stock in a report on Friday. Weiss Ratings reissued a “hold (c-)” rating on shares of Exponent in a report on Tuesday, April 21st. Finally, UBS Group dropped their target price on Exponent from $85.00 to $75.00 and set a “neutral” rating on the stock in a report on Friday, May 1st. Two equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, Exponent presently has a consensus rating of “Moderate Buy” and an average target price of $77.50.

Exponent Company Profile

Exponent, Inc (NASDAQ: EXPO) is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company’s expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.

Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.